jbrown33	10.1200/JCO.2017.35.15_suppl.TPS591	<http://dx.doi.org/10.1200/jco.2017.35.15_suppl.tps591>; rel="canonical"	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:j.0="http://purl.org/dc/terms/" xmlns:j.1="http://prismstandard.org/namespaces/basic/2.1/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:j.2="http://purl.org/ontology/bibo/" xmlns:j.3="http://xmlns.com/foaf/0.1/"><rdf:Description rdf:about="http://dx.doi.org/10.1200/JCO.2017.35.15_suppl.TPS591"><j.2:doi>10.1200/jco.2017.35.15_suppl.tps591</j.2:doi><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/emma-mcmurtry-16gm7lr3eyq2z"><j.3:name>Emma McMurtry</j.3:name><j.3:familyName>McMurtry</j.3:familyName><j.3:givenName>Emma</j.3:givenName></j.3:Person></j.0:creator><j.1:endingPage>TPS591</j.1:endingPage><j.0:identifier>10.1200/jco.2017.35.15_suppl.tps591</j.0:identifier><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/saba-mahmud-16gm7lr3eyq2z"><j.3:name>Saba Mahmud</j.3:name><j.3:familyName>Mahmud</j.3:familyName><j.3:givenName>Saba</j.3:givenName></j.3:Person></j.0:creator><j.1:volume>35</j.1:volume><j.1:doi>10.1200/jco.2017.35.15_suppl.tps591</j.1:doi><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/helena-margaret-earl-16gm7lr3eyq2z"><j.3:name>Helena Margaret Earl</j.3:name><j.3:familyName>Earl</j.3:familyName><j.3:givenName>Helena Margaret</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/ellen-copson-16gm7lr3eyq2z"><j.3:name>Ellen Copson</j.3:name><j.3:familyName>Copson</j.3:familyName><j.3:givenName>Ellen</j.3:givenName></j.3:Person></j.0:creator><j.0:isPartOf><j.2:Journal rdf:about="http://id.crossref.org/issn/0732-183X"><j.1:issn>1527-7755</j.1:issn><j.2:issn>1527-7755</j.2:issn><owl:sameAs>urn:issn:1527-7755</owl:sameAs><owl:sameAs>urn:issn:0732-183X</owl:sameAs><j.0:title>Journal of Clinical Oncology</j.0:title><j.1:issn>0732-183X</j.1:issn><j.2:issn>0732-183X</j.2:issn></j.2:Journal></j.0:isPartOf><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/elena-provenzano-16gm7lr3eyq2z"><j.3:name>Elena Provenzano</j.3:name><j.3:familyName>Provenzano</j.3:familyName><j.3:givenName>Elena</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/caron-harvey-16gm7lr3eyq2z"><j.3:name>Caron Harvey</j.3:name><j.3:familyName>Harvey</j.3:familyName><j.3:givenName>Caron</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/luke-hughes-davies-16gm7lr3eyq2z"><j.3:name>Luke Hughes-Davies</j.3:name><j.3:familyName>Hughes-Davies</j.3:familyName><j.3:givenName>Luke</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/louise-grybowicz-16gm7lr3eyq2z"><j.3:name>Louise Grybowicz</j.3:name><j.3:familyName>Grybowicz</j.3:familyName><j.3:givenName>Louise</j.3:givenName></j.3:Person></j.0:creator><j.2:pageEnd>TPS591</j.2:pageEnd><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/rebecca-roylance-16gm7lr3eyq2z"><j.3:name>Rebecca Roylance</j.3:name><j.3:familyName>Roylance</j.3:familyName><j.3:givenName>Rebecca</j.3:givenName></j.3:Person></j.0:creator><j.0:publisher>American Society of Clinical Oncology (ASCO)</j.0:publisher><owl:sameAs rdf:resource="info:doi/10.1200/jco.2017.35.15_suppl.tps591"/><j.2:volume>35</j.2:volume><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/wendi-qian-16gm7lr3eyq2z"><j.3:name>Wendi Qian</j.3:name><j.3:familyName>Qian</j.3:familyName><j.3:givenName>Wendi</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/marc-tischkowitz-16gm7lr3eyq2z"><j.3:name>Marc Tischkowitz</j.3:name><j.3:familyName>Tischkowitz</j.3:familyName><j.3:givenName>Marc</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/jessica-brown-16gm7lr3eyq2z"><j.3:name>Jessica Brown</j.3:name><j.3:familyName>Brown</j.3:familyName><j.3:givenName>Jessica</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/karen-mcadam-16gm7lr3eyq2z"><j.3:name>Karen McAdam</j.3:name><j.3:familyName>McAdam</j.3:familyName><j.3:givenName>Karen</j.3:givenName></j.3:Person></j.0:creator><j.0:date rdf:datatype="http://www.w3.org/2001/XMLSchema#date" >2017-05-20</j.0:date><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/jean-abraham-16gm7lr3eyq2z"><j.3:name>Jean Abraham</j.3:name><j.3:familyName>Abraham</j.3:familyName><j.3:givenName>Jean</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/stanly-thomas-16gm7lr3eyq2z"><j.3:name>Stanly Thomas</j.3:name><j.3:familyName>Thomas</j.3:familyName><j.3:givenName>Stanly</j.3:givenName></j.3:Person></j.0:creator><owl:sameAs rdf:resource="http://dx.doi.org/10.1200/jco.2017.35.15_suppl.tps591"/><j.0:title>PARTNER: Randomised, phase II/III trial to evaluate the safety and efficacy of the addition of olaparib to platinum-based neoadjuvant chemotherapy in triple negative and/or germline BRCA mutated breast cancer patients.</j.0:title><j.1:startingPage>TPS591</j.1:startingPage><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/anne-laure-vallier-16gm7lr3eyq2z"><j.3:name>Anne-Laure Vallier</j.3:name><j.3:familyName>Vallier</j.3:familyName><j.3:givenName>Anne-Laure</j.3:givenName></j.3:Person></j.0:creator><j.2:pageStart>TPS591</j.2:pageStart><owl:sameAs rdf:resource="doi:10.1200/jco.2017.35.15_suppl.tps591"/></rdf:Description></rdf:RDF>
